Poulam M. Patel

Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Carlos H. Barrios, Tae Min Kim et al. · Journal of Clinical Oncology · 2014 · 426 citations · Full text

Proteomic analysis of melanoma‐derived exosomes by two‐dimensional polyacrylamide gel electrophoresis and mass spectrometry

Rainy Mears, Rachel A. Craven, Sarah Hanrahan et al. · PROTEOMICS · 2004 · 331 citations

Immunology, Biological Mass Spectrometry, Immunoediting +24

IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines

Xingwu Zhu, Lori A Mulcahy, Rabab Mohammed et al. · Breast Cancer Research · 2008 · 245 citations · Full text

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Michele Maio, Karl D. Lewis, Lev Demidov et al. · The Lancet Oncology · 2018 · 210 citations · Full text

Medicine, Melanoma, Immunology +10

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)

Poulam M. Patel, Stefan Suciu, Laurent Mortier et al. · European Journal of Cancer · 2011 · 209 citations

Eortc 18032, Medicine, Melanoma +6